微博
加入微博一起分享新鲜事
登录
|
注册
140
Genentech’s Ocrevus Twice-Yearly, 10-Minute Subcutaneous Injection Was Non-Inferior to Intravenous Infusion and Provided Near-Complete Suppression of Brain Lesions https://www.mscare.org/genentechs-ocrevus-twice-yearly-10-minute-subcutaneous-injection-was-non-inferior-to-intrave
请登录并选择要私信的好友
300
Genentech’s Ocrevus Twice-Yearly, 10-Minute Subcutaneous Injection Was Non-Inferior to Intravenous Infusion and Provided Near-Complete Suppression of Brain Lesions https://www.mscare.org/genentechs-ocrevus-twice-yearly-10-minute-subcutaneous-injection-was-non-inferior-to-intrave
已选择
0
张，还能选择
1
张
来自互联网
赞一下这个内容
公开
分享
获取分享按钮
正在发布微博，请稍候
